Stockscreener 앱 받기
4.955
0.70%
-0.035
Bausch Health Companies Inc 주식(BHC)의 최신 뉴스
Actinic Keratosis Market to Witness Transformational Growth Opportunities by 2036 – DelveInsight | Almirall, Biofrontera Pharma, Vidac Pharma, Rubedo Life Sciences, Bausch Health, Sandoz Pharma - Barchart.com
TSX Healthcare Stocks: Which Names Are Drawing Market Attention? - Kalkine Media
BHC Q1 2026 Earnings: EPS Surges 12.33% Above Estimates, Shares Edge HigherEarnings Surprise Score - newsline.com
Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance sign letter of intent for public drug plan coverage of (Pr)OKEDI® (Risperidone for extended-release injectable suspension) for the treatment of schizophrenia - Cantech Letter
Why Bausch Health Companies Inc stock is sliding today - Wealth Awesome
Barclays Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $7 - Moomoo
Is Bausch Health Finally Finding Its Comeback Moment? - Kalkine Media
Bausch Health: Invest In The Short-Term Bonds, Not The Stock (NYSE:BHC) - Seeking Alpha
Valeant Investors Should Get Cert. In PwC Fight, Report Says - Law360
Bausch Health Companies stock (CA0717341071): Canadian pharma name in focus after fresh institutiona - AD HOC NEWS
Bausch (BHC) Down 5.4% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Only 217 brands in China hold this mark. Thermage just earned it - Stock Titan
Bausch Health's Aesthetic Business, Solta Medical, Earns Prestigious Trademark Certification of Thermage® in China - PR Newswire
TSX Pharma Companies Building Regional Healthcare Reach - Kalkine Media
Bausch Health (BHC) director Amy Wechsler granted $250,000 in RSUs - Stock Titan
Bausch Health (NYSE: BHC) grants $250,000 RSU award to director Eiry Roberts - Stock Titan
Bausch Health (NYSE: BHC) director receives $250,000 RSU equity grant - Stock Titan
John Paulson (BHC) receives $250K RSU award and reports large fund holdings - Stock Titan
Bausch Health (BHC) director awarded $250K in RSUs - Stock Titan
Bausch Health (BHC) director awarded $250K in restricted share units - Stock Titan
Bausch Health (BHC) director Sarah Kavanagh receives $250,000 RSU grant - Stock Titan
Bausch Health (NYSE: BHC) director awarded 45,871 RSUs valued at $250,000 - Stock Titan
Director Garcia (BHC) receives $250,000 restricted share grant in Form 4 - Stock Titan
BHC Q1 2026 Earnings: EPS Surprises to the Upside Amidst Operational ExecutionGuidance Downgrade Alert - newsline.com
Bausch Health Cos (BHC) Stock Price, News & Analysis $BHC - MarketBeat
Oligometastatic Disease Market Analysis Report 2026-2036, Profiles of Leading PlayersDompe Farmaceutici, Bausch Health, Merck, Pfizer, and Glenmark Pharmaceuticals - Yahoo Finance
Bausch Health (NYSE: BHC) director sells 24,456 shares under plan - Stock Titan
New Bausch Health (BHC) director Eiry Roberts added as insider on Form 3 - Stock Titan
BHC: Sustained growth, China expansion, and BLCO monetization drive strategic priorities - TradingView
Bausch Health shareholders elect board members and approve auditor at annual meeting By Investing.com - Investing.com South Africa
Bausch Health shareholders elect board members and approve auditor at annual meeting - Investing.com
Shareholders of Bausch Health (NYSE: BHC) approve directors, pay and PwC - Stock Titan
Eiry Roberts to chair Bausch Health science and technology committee - Stock Titan
[144] Bausch Health Companies Inc. SEC Filing - Stock Titan
Bausch + Lomb launches PreserVision AREDS3 eye vitamins in U.S. By Investing.com - Investing.com Australia
Bausch + Lomb launches PreserVision AREDS3 eye vitamins in U.S. - Investing.com UK
Cannabis Pharmaceuticals Business Research Report 2026: An - GlobeNewswire
Cannabis Pharmaceuticals Business Research Report 2026: An $111.1 Billion Market by 2032 from $4.7 Billion in 2025 Featuring AbbVie, Aphria, Aurora Cannabis, Bausch Health, and Canopy Growth - Yahoo Finance
Bausch Health rises on Q1 double beat, 2026 guidance - MSN
Bausch Health Companies (BHC) price target decreased by 10.52% to 6.72 - MSN
Dry Eye Products Market Will Generate Booming Growth - openPR.com
BHC Stock Price, Quote & Chart | BAUSCH HEALTH COS INC (NYSE:BHC) - ChartMill
Bausch Health to Participate in RBC Capital Markets 2026 Global Healthcare Conference - The Globe and Mail
Hear Bausch Health chiefs in live RBC healthcare chat May 20 - Stock Titan
Bausch Health to Participate in Barclays 30th Annual Leveraged Finance Conference - 富途牛牛
Why BauschHealth (BHC) might be the steady performer you need (Technical Weakness) 2026-05-11IV Crush Alert - newsline.com
Bausch Health's Q1 Total Prescriptions Hurt by Exit From Federal Drug Pricing Programs, RBC Says - Moomoo
Bausch Health Cos (BHC) Earnings Date and Reports 2026 $BHC - MarketBeat
Bausch Health to redeem ~$602M of outstanding notes due 2026 - MSN
Bausch + Lomb Launches Bi-Blade+™ Dual-Port Vitrectomy Cutter in Europe – Company Announcement - Financial Times
Bausch Health: Strong Margins, Weak Volumes, Equity Story Hinges On Deleveraging - Seeking Alpha
How many employees work at Solta Medical? - Revelio Labs
Bausch Health (BHC) Q1 2026 Earnings Transcript - AOL.com
Bausch Health Companies Inc. (NYSE:BHC) Q1 2026 Earnings Call Transcript - Insider Monkey
MSN Money - MSN
6.96%
0.04%
자본화:
|
볼륨(24시간):